Tapentadol is partially metabolized because of the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medicines that enhance or repress the exercise/expression of a number of of those enzymes, in addition to with substrates of these enzymes (on account of Competitiveness for your enzyme); some enzyme mediators/substrat